VSee Health, Inc. Other Income and Expense
VSee Health, Inc. (VSEE) reported Other Income and Expense of -$401.01 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Other Income
us-gaap:NonoperatingIncomeExpense · last filed 2026-08-14
- VSee Health, Inc. nonoperating income (expense) for the quarter ending 2026-06-30 was -$401.01K.
- VSee Health, Inc. nonoperating income (expense) for the quarter ending 2026-03-31 was $397.75K.
- VSee Health, Inc. nonoperating income (expense) for the quarter ending 2025-12-31 was -$4.36M.
- VSee Health, Inc. nonoperating income (expense) for the quarter ending 2025-09-30 was $1.77M, a 59.65% decline year-over-year.
- VSee Health, Inc. nonoperating income (expense) for fiscal 2025 was -$5.06M, a 280.39% decline from fiscal 2024.
- VSee Health, Inc. nonoperating income (expense) for fiscal 2024 was $2.81M.
- VSee Health, Inc. nonoperating income (expense) for fiscal 2023 was -$13.38K, a 102.48% decline from fiscal 2022.
- VSee Health, Inc. nonoperating income (expense) for fiscal 2022 was $539.69K.
| Period end | Nonoperating Income (Expense) 3 month | Nonoperating Income (Expense) 3 month as first filed | Nonoperating Income (Expense) 4 month | Nonoperating Income (Expense) 6 month | Nonoperating Income (Expense) 6 month as first filed | Nonoperating Income (Expense) 9 month | Nonoperating Income (Expense) 9 month as first filed | Nonoperating Income (Expense) 12 month | Nonoperating Income (Expense) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$401.01K 10-Q · filed 2026-08-14 | $17.89K 10-Q · filed 2026-08-14 | -$4.36M derived: sum of 3 quarters · filed 2026-08-14 | -$2.60M derived: sum of 4 quarters · filed 2026-08-14 | |||||
| 2026-03-31 | $397.75K 10-Q · filed 2026-05-15 | -$3.96M derived: sum of 2 quarters · filed 2026-05-15 | -$2.20M derived: sum of 3 quarters · filed 2026-05-15 | -$2.54M derived: sum of 4 quarters · filed 2026-08-14 | |||||
| 2025-12-31 | -$4.36M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$2.59M derived: sum of 2 quarters · filed 2026-03-31 | -$2.94M derived: sum of 3 quarters · filed 2026-08-14 | -$5.06M 10-K · filed 2026-03-31 | |||||
| 2025-09-30 | $1.77M 10-Q · filed 2025-11-14 | $1.42M derived: sum of 2 quarters · filed 2026-08-14 | -$700.90K 10-Q · filed 2025-11-14 | -$847.01K derived: sum of 4 quarters · filed 2026-08-14 | |||||
| 2025-06-30 | -$346.14K 10-Q · filed 2026-08-14 | -$354.06K 10-Q · filed 2025-10-15 | -$2.42M 10-Q · filed 2026-08-14 | -$2.47M 10-Q · filed 2025-10-15 | -$2.61M derived: sum of 3 quarters · filed 2026-08-14 | $1.77M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-03-31 | -$2.11M 10-Q · filed 2026-05-15 | -$2.27M derived: sum of 2 quarters · filed 2026-05-15 | $2.11M derived: sum of 3 quarters · filed 2026-05-15 | $700.62K derived: sum of 4 quarters · filed 2026-05-15 | |||||
| 2024-12-31 | -$154.03K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $4.23M derived: sum of 2 quarters · filed 2026-03-31 | $2.82M derived: sum of 3 quarters · filed 2026-03-31 | $2.81M 10-K · filed 2026-03-31 | |||||
| 2024-09-30 | $4.38M 10-Q · filed 2025-11-14 | $4.76M 10-Q · filed 2024-11-14 | $2.97M derived: sum of 2 quarters · filed 2025-11-20 | $2.96M 10-Q · filed 2025-11-14 | $3.34M 10-Q · filed 2024-11-14 | $3.00M derived: sum of 4 quarters · filed 2025-11-20 | |||
| 2024-06-30 | -$1.41M 10-Q/A · filed 2025-11-20 | -$1.42M 10-Q · filed 2024-09-23 | -$1.42M 10-Q/A · filed 2025-11-20 | -$1.43M 10-Q · filed 2024-09-23 | -$1.38M derived: sum of 3 quarters · filed 2025-11-20 | -$1.44M derived: sum of 4 quarters · filed 2025-11-20 | |||
| 2024-03-31 | -$9.31K 10-Q · filed 2025-10-15 | -$293.56K 10-Q · filed 2024-05-15 | $28.82K derived: sum of 2 quarters · filed 2025-10-15 | -$29.12K derived: sum of 3 quarters · filed 2025-10-15 | -$20.97K derived: sum of 4 quarters · filed 2025-10-15 | ||||
| 2023-12-31 | $38.13K derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-08-29 | -$19.81K derived: sum of 2 quarters · filed 2025-08-29 | -$11.66K derived: sum of 3 quarters · filed 2025-08-29 | -$13.38K 10-K/A · filed 2025-08-29 | -$1.82M 10-K · filed 2024-04-12 | ||||
| 2023-09-30 | -$57.94K 10-Q · filed 2024-11-14 | $596.37K 10-Q · filed 2023-11-20 | -$49.79K derived: sum of 2 quarters · filed 2024-11-14 | -$51.51K 10-Q · filed 2024-11-14 | $115.30K 10-Q · filed 2023-11-20 | -$1.17M derived: sum of 4 quarters · filed 2024-11-14 | |||
| 2023-06-30 | $8.15K 10-Q · filed 2024-09-23 | $705.98K 10-Q · filed 2023-08-21 | $6.43K 10-Q · filed 2024-09-23 | -$481.07K 10-Q · filed 2023-08-21 | -$1.11M derived: sum of 3 quarters · filed 2024-09-23 | -$717.73K derived: sum of 4 quarters · filed 2024-09-23 | |||
| 2023-03-31 | -$1.19M 10-Q · filed 2024-05-15 | -$1.12M derived: sum of 2 quarters · filed 2024-05-15 | -$725.88K derived: sum of 3 quarters · filed 2024-05-15 | -$663.18K derived: sum of 4 quarters · filed 2024-05-15 | |||||
| 2022-12-31 | $69.54K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-12 | $461.17K derived: sum of 2 quarters · filed 2024-04-12 | $523.87K derived: sum of 3 quarters · filed 2024-04-12 | $539.69K 10-K · filed 2024-04-12 | |||||
| 2022-09-30 | $391.63K 10-Q · filed 2023-11-20 | $454.33K derived: sum of 2 quarters · filed 2023-11-20 | $470.15K 10-Q · filed 2023-11-20 | ||||||
| 2022-06-30 | $62.70K 10-Q · filed 2023-08-21 | $78.52K 10-Q · filed 2023-08-21 | |||||||
| 2022-03-31 | $15.82K 10-Q · filed 2023-05-15 | ||||||||
| 2021-12-31 | $1.97K 10-K · filed 2023-04-12 | ||||||||
| 2021-06-30 | -$5.00K 10-Q · filed 2022-08-15 | -$5.00K 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Agape ATP Corp (ATPC) | $0.002B | ||
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |